These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1088 related articles for article (PubMed ID: 33736721)

  • 1. Clinical illness with viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) virus presenting 72 days after infection in an immunocompromised patient.
    Hughes CM; Gregory GP; Pierce AB; Druce JD; Catton M; Chong B; Sherry NL; Graham M; Chen M; Salvaris R; Eise N; Lee JYH; McQuilten Z; Crouch S; Looker C; Korman TM; Stuart RL
    Infect Control Hosp Epidemiol; 2022 Jun; 43(6):820-822. PubMed ID: 33736721
    [No Abstract]   [Full Text] [Related]  

  • 2. Genomic Evolution of SARS-CoV-2 Virus in Immunocompromised Patient, Ireland.
    Lynch M; Macori G; Fanning S; O'Regan E; Hunt E; O'Callaghan D; McCullagh B; Jennings C; Fortune A
    Emerg Infect Dis; 2021 Sep; 27(9):2499-2501. PubMed ID: 34161223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 in an immunocompromised host: persistent shedding of viable SARS-CoV-2 and emergence of multiple mutations: a case report.
    Leung WF; Chorlton S; Tyson J; Al-Rawahi GN; Jassem AN; Prystajecky N; Masud S; Deans GD; Chapman MG; Mirzanejad Y; Murray MCM; Wong PHP
    Int J Infect Dis; 2022 Jan; 114():178-182. PubMed ID: 34757008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged viral shedding of SARS-CoV-2 in two immunocompromised patients, a case report.
    Niyonkuru M; Pedersen RM; Assing K; Andersen TE; Skov MN; Johansen IS; Madsen LW
    BMC Infect Dis; 2021 Aug; 21(1):743. PubMed ID: 34344321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of long-range severe acute respiratory coronavirus virus 2 (SARS-CoV-2) transmission from a highly infectious patient with undiagnosed coronavirus disease 2019 (COVID-19) in a positive-pressure room.
    Rhee C; Baker MA; Tucker R; Klompas M
    Infect Control Hosp Epidemiol; 2022 Jan; 43(1):108-109. PubMed ID: 34287114
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 in Elderly, Immunocompromised or Diabetic Patients-From Immune Monitoring to Clinical Management in the Hospital.
    Wünsch K; Anastasiou OE; Alt M; Brochhagen L; Cherneha M; Thümmler L; van Baal L; Madel RJ; Lindemann M; Taube C; Witzke O; Rohn H; Krawczyk A; Jansen S
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yearlong COVID-19 Infection Reveals Within-Host Evolution of SARS-CoV-2 in a Patient With B-Cell Depletion.
    Nussenblatt V; Roder AE; Das S; de Wit E; Youn JH; Banakis S; Mushegian A; Mederos C; Wang W; Chung M; Pérez-Pérez L; Palmore T; Brudno JN; Kochenderfer JN; Ghedin E
    J Infect Dis; 2022 Apr; 225(7):1118-1123. PubMed ID: 34940844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in the Immunocompromised Patient: New Challenges and Urgent Needs.
    Lodi L; Moriondo M; Pucci A; Pisano L; Ricci S; Indolfi G; Azzari C
    Clin Infect Dis; 2022 Feb; 74(3):553. PubMed ID: 34157075
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunocompromised Seroprevalence and Course of Illness of SARS-CoV-2 in One Pediatric Quaternary Care Center.
    Freeman MC; Rapsinski GJ; Zilla ML; Wheeler SE
    J Pediatric Infect Dis Soc; 2021 Apr; 10(4):426-431. PubMed ID: 33049042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent Coronavirus Disease 2019 (COVID-19) in an Immunocompromised Host Treated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific Monoclonal Antibodies.
    Bailly B; Péré H; Veyer D; Berceanu A; Daguindau E; Roux P; Hermine O; de Lamballerie X; Bastard P; Lacombe K; Autran B; Angelot Delettre F; Laurent Casanova J; Imbeaud S; Laure Clairet A; Kroemer M; Spehner L; Robillard N; Puech J; Marty-Quinternet S; Lepiller Q; Chirouze C; Bouiller K
    Clin Infect Dis; 2022 May; 74(9):1706-1707. PubMed ID: 34598278
    [No Abstract]   [Full Text] [Related]  

  • 12. Finding the off-ramp: Rethinking severe acute respiratory coronavirus virus 2 (SARS-CoV-2) preoperative screening.
    Penney JA; Doron SI
    Infect Control Hosp Epidemiol; 2022 Jul; 43(7):918-919. PubMed ID: 34986925
    [No Abstract]   [Full Text] [Related]  

  • 13. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of four cancer patients with SARS-CoV-2 infection in Wuhan, China.
    Song SH; Chen TL; Deng LP; Zhang YX; Mo PZ; Gao SC; Hu WJ; Xiong Y; Ma ZY
    Infect Dis Poverty; 2020 Jul; 9(1):82. PubMed ID: 32616030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy.
    Truffot A; Andréani J; Le Maréchal M; Caporossi A; Epaulard O; Germi R; Poignard P; Larrat S
    Emerg Infect Dis; 2021 Oct; 27(10):2725-2728. PubMed ID: 34352197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19.
    Burrel S; Hausfater P; Dres M; Pourcher V; Luyt CE; Teyssou E; Soulié C; Calvez V; Marcelin AG; Boutolleau D
    Int J Infect Dis; 2021 Jan; 102():10-13. PubMed ID: 33115679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroconversion in hematology-oncology patients.
    Bird PW; Badhwar V; Kennedy B; Ladani S; Tang JW
    J Med Virol; 2021 Jul; 93(7):4585-4591. PubMed ID: 33595119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinfection of Severe Acute Respiratory Syndrome Coronavirus 2 in an Immunocompromised Patient: A Case Report.
    Mulder M; van der Vegt DSJM; Oude Munnink BB; GeurtsvanKessel CH; van de Bovenkamp J; Sikkema RS; Jacobs EMG; Koopmans MPG; Wegdam-Blans MCA
    Clin Infect Dis; 2021 Nov; 73(9):e2841-e2842. PubMed ID: 33043962
    [No Abstract]   [Full Text] [Related]  

  • 19. Test-based de-isolation in COVID-19 immunocompromised patients: Cycle threshold value versus SARS-CoV-2 viral culture.
    Alshukairi AN; Tolah AM; Dada A; Al-Tawfiq JA; Almagharbi RS; Saeedi MF; Al-Hamzi MA; El-Kafrawy SA; Bahaudden HA; El-Saed A; Al-Mozaini MA; Khalid I; Hefni LK; Hassan AM; Alandijany TA; Bajrai LH; Bayumi DT; Albishi GE; Althawadi SI; Zabani NA; Perlman S; Azhar EI
    Int J Infect Dis; 2021 Jul; 108():112-115. PubMed ID: 34004329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Respiratory Aerosols Emitted by Patients With Coronavirus Disease 2019 (COVID-19) While Breathing, Talking, and Singing.
    Coleman KK; Tay DJW; Tan KS; Ong SWX; Than TS; Koh MH; Chin YQ; Nasir H; Mak TM; Chu JJH; Milton DK; Chow VTK; Tambyah PA; Chen M; Tham KW
    Clin Infect Dis; 2022 May; 74(10):1722-1728. PubMed ID: 34358292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.